For those of you with medical schools, how do your institutions handle the
administration and review of the contracts for clinical studies sponsored by
drug companies to ensure that they are in compliance with university policy
and practice?

More specifically,  (1.) is there a designated person(s) that handles these
contracts or are the responsibilities divided up among various people or
even various offices?
(2.)Which office/division is responsible for any negotiated changes required?

We are evaluating our procedure here at Tulane with an eye towards
streamlining operations and could use some input.

Please reply to xxxxxx@tmcpop.tmc.tulane.edu--we will post a summary in case
anyone else is interested.  Thank you.